Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

FENNEC PHARMACEUTICALS INC. Director's Dealing 2024

Nov 4, 2024

35599_dirs_2024-11-04_474dede6-11b5-4cec-8c6d-737d53cf2b03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-10-28

Reporting Person: Cioffi Christiana Marie (N/A)

More from FENNEC PHARMACEUTICALS INC.

Regulatory Filings 2026
May 22
Regulatory Filings 2026
May 18
Interim / Quarterly Report 2026
May 14
Regulatory Filings 2026
Apr 28
Regulatory Filings 2026
Apr 7
Annual Report 2026
Mar 27
Regulatory Filings 2026
Mar 24
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Regulatory Filings 2026
Feb 20
View all filings →